is januvia a glp 1 agonist Sitagliptin/Metformin (Janumet) as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus Glucagon-like peptide-1 receptor: mechanisms and

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety

Type 2 diabetes represents a growing challenge for global public health

For food and beverage companies, understanding how their use might evolve will be critical to staying relevant, from reformulating products to meeting new nutritional needs